Xenetic Biosciences, Inc.
XBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534525
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Xenetic Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +3 vs. Q3 2022
- Shares held
- 694.1K
- −298.6K (−30.1%) vs. Q3 2022
- Total value
- $197.6K
- −$337.4K (−63.1%) vs. Q3 2022
- New holders
- 7
- 3 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $442.8K |
| Q1 2026 | 6 | $453.0K |
| Q4 2025 | 11 | $496.6K |
| Q3 2025 | 10 | $183.7K |
| Q2 2025 | 9 | $250.2K |
| Q1 2025 | 13 | $293.1K |
| Q4 2024 | 13 | $356.1K |
| Q3 2024 | 9 | $211.6K |
| Q2 2024 | 5 | $62.0K |
| Q1 2024 | 7 | $73.8K |
| Q4 2023 | 7 | $60.7K |
| Q3 2023 | 7 | $79.4K |
| Q2 2023 | 9 | $120.4K |
| Q1 2023 | 19 | $235.3K |
| Q4 2022 | 19 | $197.6K |
| Q3 2022 | 16 | $535.0K |
| Q2 2022 | 15 | $828.0K |
| Q1 2022 | 14 | $1.07M |
| Q4 2021 | 22 | $1.88M |
| Q3 2021 | 19 | $3.43M |
| Q2 2021 | 14 | $832.2K |
| Q1 2021 | 12 | $1.22M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Xenetic Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 158,623 | $45.2K | 0.00% | −457,844−74.3% | Reduced |
| Renaissance Technologies LLC | 143,400 | $41.0K | 0.00% | +28,300+24.6% | Added |
| Geode Capital Management, LLC | 92,343 | $26.0K | 0.00% | −258−0.3% | Reduced |
| HRT Financial LP | 56,465 | $16.0K | 0.00% | +56,465 | New |
| Jane Street Group, LLC | 39,767 | $11.3K | 0.00% | +39,767 | New |
| State Street Corp | 34,668 | $9.91K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 32,568 | $9.31K | 0.00% | +32,568 | New |
| JTC Employer Solutions Trusteee Ltd | 26,991 | $8.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 25,040 | $7.16K | 0.00% | +25,040 | New |
| Steward Partners Investment Advisory, LLC | 19,000 | $5.42K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 18,826 | $5.38K | 0.00% | +18,826 | New |
| Northern Trust Corp | 17,760 | $5.06K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 10,600 | $3.02K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,354 | $3.00K | 0.00% | −336−2.9% | Reduced |
| Morgan Stanley | 5,969 | $1.70K | 0.00% | +17+0.3% | Added |
| NewSquare Capital LLC | 260 | $74 | 0.00% | +260 | New |
| Wells Fargo & Company | 103 | $29 | 0.00% | +8+8.4% | Added |
| FMR LLC | 18 | $5 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 300 | $0 | 0.00% | +300 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,734−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,964−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,857−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |